SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits

Journal of the Neurological Sciences

Volumn 153, Issue 1, 1997, Pages 25-31

  Perez Pinzon, Miguel A ^a   Yenari, Midori A ^a   Sun, Guo H ^a   Kunis, David M ^a   Steinberg, Gary K ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Calcium; Conopeptides; Excitotoxicity; Focal cerebral ischemia; MVIIA; Rabbit; Stroke

Indexed keywords

CALCIUM CHANNEL; NEUROPROTECTIVE AGENT; OMEGA CONOTOXIN MVIIA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PROTECTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; EVOKED SOMATOSENSORY RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STROKE;

ANIMALS; BLOOD PRESSURE; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR CIRCULATION; EVOKED POTENTIALS, SOMATOSENSORY; MAGNETIC RESONANCE IMAGING; MALE; NEUROPROTECTIVE AGENTS; OMEGA-CONOTOXINS; PEPTIDES; RABBITS;

EID: 0031460496     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00196-2     Document Type: Article

References (45)

1. Berger J.R., Busto R., Ginsberg M.D. Verapamil: failure of metabolic amelioration following global forebrain ischemia in the rat. Stroke. 15:1984;1029-1032.
2. Bielenberg G.W., Beck T. The effects of dizocilpine (MK-801), phencyclidine, and nimodipine on infarct size 48 h after middle cerebral artery occlusion in the rat. Brain Res. 552:1991;338-342.
3. Bowersox S.S., Singh T., Nadasdi L., Zukowska-Grojec Z., Valentino K., Hoffman B.B. Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action. J. Cardiovasc. Pharmacol. 20:1992;756-764.
4. Buchan A.M., Gertler S.Z., Li H., Xue D., Huang Z.G., Chaundy K.E., Barnes K., Lesiuk H.J. A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. J. Cereb. Blood Flow Metab. 14:1994;903-910.
5. Cheng B., Mattson M.P. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12:1992;1558-1566.
6. DeLaPaz R.L., Shibata D., Steinberg G.K., Zarnegar R., George C. Acute cerebral ischemia in rabbits: correlation between MR and histopathology. Am. J. Neuroradiol. 12:1991;89-95.
7. Dereski M.O., Chopp M., Knight R.A., Rodolosi L.C., Garcia J.H. The heterogeneous temporal evolution of focal ischemic neuronal damage in the rat. Acta Neuropathol. (Berlin). 85:1993;327-333.
8. Dirnagl U., Kaplan B., Jacewicz M., Pulsinelli W. Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model. J. Cereb. Blood Flow Metab. 9:1989;589-596.
9. Gibbons S.J., Brorson J.R., Bleakman D., Chard P.S., Miller R.J. Calcium influx and neurodegeneration. Ann. NY Acad. Sci. 679:1993;22-33.
10. Ginsberg M.D., Budd M.W., Welsh F.A. Diffuse cerebral ischemia in the cat: I. Local blood flow during severe ischemia and recirculation. Ann. Neurol. 3:1978;482-492.
11. Hillyard D.R., Monje V.D., Mintz I.M., Bean B.P., Nadasdi L., Ramachandran J., Miljanich G., Azimi-Zoonooz A., McIntosh J.M., Cruz L.J., Imperial J.S., Baldomero O.M. A new Conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron. 9:1992;69-77.
12. Jacewicz M., Brint S., Tanabe J., Wang X.J., Pulsinelli W.A. Nimodipine pretreatment improves cerebral blood flow and reduces brain edema in conscious rats subjected to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 10:1990;903-913.
13. Lipton P., Lobner D. Mechanisms of intracellular calcium accumulation in the CA1 region of rat hippocampus during anoxia in vitro. Stroke. 21:1990;III60-64.
14. Madden K.P., Clark W.M., Marcoux F.W., Probert A.W. Jr., Weber M.L., Rivier J., Zivin J.A. Treatment with conotoxin, an 'N-type' calcium channel blocker, in neuronal hypoxic-ischemic injury. Brain Res. 537:1990;256-262.
15. Maier C., Steinberg G.K., Sun G.H., Zhi G.T., Maze M. Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology. 79:1993;306-312.
16. Mattson M.P., Guthrie P.B., Kater S.B. Intracellular messengers in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. Res. 21:1988;447-464.
17. McCleskey E.W., Fox A.P., Feldman D.H., Cruz L.J., Olivera B.M., Tsien R.W., Yoshikami D. Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc. Natl. Acad. Sci. USA. 84:1987;4327-4331.
18. Milde L.N., Milde J.H., Michenfelder J.D. Delayed treatment with nimodipine improves cerebral blood flow after complete cerebral ischemia in the dog. J. Cereb. Blood Flow Metab. 6:1986;332-337.
19. Obaid A.L., Flores R., Salzberg B.M. Calcium channels that are required for secretion from intact nerve terminals of vertebrates are sensitive to omega-conotoxin and relatively insensitive to dihydropyridines. Optical studies with and without voltage-sensitive dyes. J. Gen. Physiol. 93:1989;715-729.
20. Olivera B.M., Cruz L.J., de Santos V., LeCheminant G.W., Griffin D., Zeikus R., McIntosh J.M., Galyean R., Varga J., Gray W.R., Rivier J. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry. 26:1987;2086-2090.
21. Perez-Pinzon M.A., Maier C.M., Yoon E.J., Sun G.H., Giffard R.G., Steinberg G.K. Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15:1995;865-876.
22. Pringle A., Benham C., Sim L., Kennedy J., Iannotti F., Sundstrom L. Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures. Stroke. 27:1996;2124-2130.
23. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498.
24. Ramilo C.A., Zafaralla G.C., Nadasdi L., Hammerland L.G., Yoshikami D., Gray W.R., Kristipati R., Ramachandran J., Miljanich G., Olivera B.M., Cruz L.J. Novel alpha- and omega-conotoxins from Conus striatus venom. Biochemistry. 31:1992;9919-9926.
25. Roda J.M., Carceller F., Diez-Tejedor E., Avendano C. Reduction of infarct size by intra-arterial nimodipine administered at reperfusion in a rat model of partially reversible brain focal ischemia. Stroke. 26(10):1995;1888-1892.
26. Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19:1986;105-111.
27. Sakaki T., Tsujimoto S., Sasaoka Y., Tsunoda S., Shintomi K. The effect of a new calcium antagonist, TA3090 (clentiazem), on experimental transient focal cerebral ischemia in cats. Stroke. 24:1993;872-878.
28. Sauter A., Rudin M. Calcium antagonists for reduction of brain damage in stroke. J. Cardiovasc. Pharmacol. 15:1990;S43-47.
29. Schurr A., Rigor B.M. The mechanism of cerebral hypoxic-ischemic damage. Hippocampus. 2:1992;221-228.
30. Schurr A., West C.A., Rigor B.M. Neurotoxicity of quinolinic acid and its derivatives in hypoxic rat hippocampal slices. Brain Res. 568:1991;199-204.
31. Siesjo B.K. Cell damage in the brain: a speculative synthesis. J. Cereb. Blood Flow Metab. 1:1981;155-185.
32. Smith, M.-L., Siesjo, B.K., 1992. Postischemia treatment with the omega-conopeptide SNX-111 protects the rat brain against ischemic damage. In: Krieglstein, J., Oberpilcher, H. (Eds.), Pharmacology of Cerbral Ischemia Stuttgart. Germany, Wissenschaftliche Verlagsgesellshft, pp. 161-167.
33. Snape M.F., Baldwin H.A., Cross A.J., Green A.R. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience. 53:1993;837-844.
34. Steen P.A., Newberg L.A., Milde J.H., Michenfelder J.D. Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J. Cereb. Blood Flow Metab. 4:1984;82-87.
35. Steinberg G.K., Gelb A.W., Lam A.M., Manninen P.H., Peerless S.J., Rassi Neto A., Floyd P. Correlation between somatosensory evoked potentials and neuronal ischemic changes following middle cerebral artery occlusion. Stroke. 17:1986;1193-1197.
36. Steinberg G.K., George C.P., DeLaPaz R., Shibata D.K., Gross T. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits. Stroke. 19:1988;1112-1118.
37. Steinberg G.K., Saleh J., Kunis D., DeLaPaz R., Zarnegar S.R. Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits. Stroke. 20:1989;1247-1252.
38. Steinberg G.K., Kunis D., Saleh J., DeLaPaz R. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels. J. Cereb. Blood Flow Metab. 11:1991;1015-1024.
39. Stys P.K., Waxman S.G., Ransom B.R. Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter. Ann. Neurol. 30:1991;375-380.
40. Takizawa S., Matsushima K., Fujita H., Nanri K., Ogawa S., Shinohara Y. A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15:1995;611-618.
41. Tsien R.W., Lipscombe D., Madison D.V., Bley K.R., Fox A.P. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 11:1988;431-438.
42. Valentino K., Newcomb R., Gadbois T., Singh T., Bowersox S., Bitner S., Justice A., Yamashiro D., Hoffman B.B., Ciaranello R., Miljanich G., Ramachandran J. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc. Natl. Acad. Sci. USA. 90:1993;7894-7897.
43. Wagner J.A., Snowman A.M., Biswas A., Olivera B.M., Snyder S.H. Omega-conotoxin GVIA binding to a high-affinity receptor in brain: characterization, calcium sensitivity, and solubilization. J. Neurosci. 8:1988;3354-3359.
44. Yenari M., Palmer J., Sun G., de Crespigny A., Moseley M., Steinberg G. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI. Brain Res. 739:1996;36-45.
45. Zhao Q., Smith M.L., Siesjo B.K. The omega-conopeptide SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischaemia. Acta Physiol. Scand. 150:1994;459-461.